Amphastar Pharmaceuticals AMPH

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.49 (+1.73%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Amphastar Pharmaceuticals (AMPH)
    Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $28.81

    • Market Cap

      $1.37 Billion

    • Price-Earnings Ratio

      8.86

    • Total Outstanding Shares

      47.65 Million Shares

    • Total Employees

      2,028

    • Dividend

      No dividend

    • IPO Date

      June 25, 2014

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      11570 sixth street, Rancho cucamonga, CA, 91730

    • Homepage

      https://www.amphastar.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Investing Activities$-192.30 Million
    Net Cash Flow, Continuing$-78.27 Million
    Net Cash Flow From Financing Activities, Continuing$-94.19 Million
    Net Cash Flow From Operating Activities, Continuing$208.23 Million
    Net Cash Flow$-78.69 Million
    Net Cash Flow From Financing Activities$-94.19 Million

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Cost Of Revenue$340.20 Million
    Income/Loss From Equity Method Investments$-1.08 Million
    Income/Loss From Continuing Operations Before Tax$187.15 Million
    Nonoperating Income/Loss$-27.11 Million
    Other Operating Expenses$92.90 Million
    Research and Development$76.19 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$157.31 Million
    Comprehensive Income/Loss$157.66 Million
    Other Comprehensive Income/Loss Attributable To Parent$-410,000
    Other Comprehensive Income/Loss$40.37 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Noncurrent Assets$999.23 Million
    Equity Attributable To Parent$727.68 Million
    Current Liabilities$159.01 Million
    Other Non-current Assets$703.85 Million
    Assets$1.55 Billion
    Fixed Assets$295.38 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AMPH from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.